Probing the Role of Feature Dimension Maps in Visual Cognition: Manipulations of Relevant Locations on Salience Processing? (Expt 3.1 Pilot)
Launched by UNIVERSITY OF CALIFORNIA, SANTA BARBARA · Feb 24, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • between 18 and 55 years of age
- • normal or corrected-to-normal vision
- Exclusion Criteria:
- • • N/A
About University Of California, Santa Barbara
The University of California, Santa Barbara (UCSB) is a leading research institution renowned for its commitment to advancing scientific knowledge and fostering innovation. As a clinical trial sponsor, UCSB leverages its interdisciplinary expertise and state-of-the-art facilities to conduct cutting-edge research that addresses critical health challenges. With a focus on collaboration across various fields, UCSB aims to translate research findings into real-world applications, ultimately improving patient outcomes and contributing to the broader medical community. The university's dedication to ethical standards and rigorous methodologies ensures the integrity and reliability of its clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Santa Barbara, California, United States
Patients applied
Trial Officials
Tommy C Sprague
Principal Investigator
University of California, Santa Barbara
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported